FDA Approved New Med for Lennox – Gastaut Syndrome
Gastaut Syndrome – FDA Approved New Med for Lennox The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in children aged 2 years and older, the company has announced. Fenfluramine is already approved in the US […]
New Drug Approvals